Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Bridge-Enhanced ACL Repair-Safety Study (BEAR Trial)

NCT: NCT02292004 · ACTIVE_NOT_RECRUITING

NCT IDNCT02292004
StatusACTIVE_NOT_RECRUITING
Start Date2015-01
Completion2026-12-31
SponsorMiach Orthopaedics (INDUSTRY)
First posted
Last updated

Brief Summary

This study will assess the safety and early efficacy of a newly developed device, bridge-enhanced scaffold (MIACH™,) used to repair a torn anterior cruciate ligament (ACL.) Ten participants will undergo surgery with the new device (Experimental Group) and 10 will undergo a standard ACL reconstruction surgery (Control Group.)

Frequently Asked Questions

What is Bridge-Enhanced ACL Repair-Safety Study (BEAR Trial)?

Bridge-Enhanced ACL Repair-Safety Study (BEAR Trial) is a clinical trial registered under NCT02292004. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT02292004?

The current status of NCT02292004 (Bridge-Enhanced ACL Repair-Safety Study (BEAR Trial)) is: ACTIVE_NOT_RECRUITING.

When did Bridge-Enhanced ACL Repair-Safety Study (BEAR Trial) start?

Bridge-Enhanced ACL Repair-Safety Study (BEAR Trial) started on 2015-01.

Related Devices

K243578BEAR® (Bridge-Enhanced ACL Restoration) ImplantMiach Orthopaedics, Inc. K251214BEAR® (Bridge-Enhanced ACL Restoration) ImplantMiach Orthopaedics, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑